Table 7.
Variable | Group | Control | D3 | p-Value |
---|---|---|---|---|
IL-1β (pg/mL) | Baseline | 3.27 ± 1.37 | 3.22 ± 0.99 | PB = 0.852 |
Follow-up | 3.59 ± 2.71 | 7.63 ± 2.36 | PC < 0.001 | |
Change | 0.32 | 4.41 | ||
PA | 0.574 | <0.001 | ||
IL-6 (pg/mL) |
Baseline | 4.55 ± 2.62 | 5.5 ± 6.51 | PB = 0.431 |
Follow-up | 4.85 ± 4.84 | 26.99 ± 14.47 | PC < 0.001 | |
Change | 0.30 | 21.49 | ||
PA | 0.750 | <0.001 | ||
TNF-α (pg/mL) |
Baseline | 31.16 ± 5.22 | 33.34 ± 6.36 | PB = 0.116 |
Follow-up | 33.65 ± 5.15 | 33.50 ± 6.18 | PC = 0.910 | |
Change | 2.49 | 0.16 | ||
PA | 0.100 | 0.899 | ||
IL-10 (pg/mL) |
Baseline | 2.20 ± 0.52 | 2.01 ± 0.59 | PB = 0.159 |
Follow-up | 2.39 ± 1.39 | 4.46 ± 4.67 | PC = 0.016 | |
Change | 0.20 | 2.45 | ||
PA | 0.433 | 0.001 |
Abbreviations: PA, p-value for paired sample t-test; PB, p-value for two independent sample t-test at baseline; PC, p-value for two independent sample t-test at follow-up of trial.